Keyword Tag
Discover 1 curated intelligence briefings related to this specific topic.
While the public focuses on weight loss, the biopharmaceutical industry is leveraging GLP-1 receptor agonists to navigate regulatory stringency and economic shocks, effectively turning metabolic drugs into the vanguard of longevity science.
